The role of the Le Fort I maxillotomy in the management of incompletely resected pituitary macroadenomas

Bruce Mickey, Leslie Hutchins, Edward Ellis

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Objective: The options available for the treatment of a nonsecreting pituitary macroadenoma that has been incompletely resected include reoperation, fractionated radiation therapy, and radiosurgery. Reoperation in this setting may be hindered by the same obstacles that prevented a complete resection during the initial surgical procedure, and should prompt consideration of an alternate approach or exposure. Methods: Between January 1998 and December 2003, 10 consecutive patients were referred to the Department of Neurosurgery at the University of Texas Southwestern Medical Center for the evaluation of a nonsecreting pituitary macroadenoma that measured 3 cm or greater in diameter despite having undergone an attempt at a complete resection elsewhere. Each of these patients was reoperated using a Le Fort I maxillotomy to enhance the exposure provided by a traditional transsphenoidal approach. Results: A total or near total (> 95%) resection was achieved in each case. One patient required reoperation for the repositioning of a fat graft to treat a cerebrospinal fluid fistula and one patient experienced a worsening of anterior pituitary function postoperatively. Five patients noted improved vision and no patient experienced further visual loss. Three patients have required subsequent treatment of small foci of recurrent or progressing tumor with stereotactic radiation therapy. No patient has received fractionated radiation therapy. Conclusion: The added exposure provided by a Le Fort I maxillotomy facilitates the resection of pituitary macroadenomas that have been incompletely resected by a traditional transnasal, trans-sphenoidal approach.

Original languageEnglish (US)
Pages (from-to)369-378
Number of pages10
JournalSkull Base
Volume17
Issue number6
DOIs
StatePublished - Nov 2007

Fingerprint

Reoperation
Radiotherapy
Radiosurgery
Neurosurgery
Fistula
Cerebrospinal Fluid
Fats
Transplants
Therapeutics
Neoplasms

Keywords

  • Le Fort I maxillotomy
  • Macroadenoma
  • Pituitary adenoma
  • Trans-sphenoidal surgery

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

The role of the Le Fort I maxillotomy in the management of incompletely resected pituitary macroadenomas. / Mickey, Bruce; Hutchins, Leslie; Ellis, Edward.

In: Skull Base, Vol. 17, No. 6, 11.2007, p. 369-378.

Research output: Contribution to journalArticle

@article{07fbff12e2b94bd58a0457bfa445b69c,
title = "The role of the Le Fort I maxillotomy in the management of incompletely resected pituitary macroadenomas",
abstract = "Objective: The options available for the treatment of a nonsecreting pituitary macroadenoma that has been incompletely resected include reoperation, fractionated radiation therapy, and radiosurgery. Reoperation in this setting may be hindered by the same obstacles that prevented a complete resection during the initial surgical procedure, and should prompt consideration of an alternate approach or exposure. Methods: Between January 1998 and December 2003, 10 consecutive patients were referred to the Department of Neurosurgery at the University of Texas Southwestern Medical Center for the evaluation of a nonsecreting pituitary macroadenoma that measured 3 cm or greater in diameter despite having undergone an attempt at a complete resection elsewhere. Each of these patients was reoperated using a Le Fort I maxillotomy to enhance the exposure provided by a traditional transsphenoidal approach. Results: A total or near total (> 95{\%}) resection was achieved in each case. One patient required reoperation for the repositioning of a fat graft to treat a cerebrospinal fluid fistula and one patient experienced a worsening of anterior pituitary function postoperatively. Five patients noted improved vision and no patient experienced further visual loss. Three patients have required subsequent treatment of small foci of recurrent or progressing tumor with stereotactic radiation therapy. No patient has received fractionated radiation therapy. Conclusion: The added exposure provided by a Le Fort I maxillotomy facilitates the resection of pituitary macroadenomas that have been incompletely resected by a traditional transnasal, trans-sphenoidal approach.",
keywords = "Le Fort I maxillotomy, Macroadenoma, Pituitary adenoma, Trans-sphenoidal surgery",
author = "Bruce Mickey and Leslie Hutchins and Edward Ellis",
year = "2007",
month = "11",
doi = "10.1055/s-2007-986426",
language = "English (US)",
volume = "17",
pages = "369--378",
journal = "Journal of Neurological Surgery, Part B: Skull Base",
issn = "2193-6331",
publisher = "Thieme Medical Publishers",
number = "6",

}

TY - JOUR

T1 - The role of the Le Fort I maxillotomy in the management of incompletely resected pituitary macroadenomas

AU - Mickey, Bruce

AU - Hutchins, Leslie

AU - Ellis, Edward

PY - 2007/11

Y1 - 2007/11

N2 - Objective: The options available for the treatment of a nonsecreting pituitary macroadenoma that has been incompletely resected include reoperation, fractionated radiation therapy, and radiosurgery. Reoperation in this setting may be hindered by the same obstacles that prevented a complete resection during the initial surgical procedure, and should prompt consideration of an alternate approach or exposure. Methods: Between January 1998 and December 2003, 10 consecutive patients were referred to the Department of Neurosurgery at the University of Texas Southwestern Medical Center for the evaluation of a nonsecreting pituitary macroadenoma that measured 3 cm or greater in diameter despite having undergone an attempt at a complete resection elsewhere. Each of these patients was reoperated using a Le Fort I maxillotomy to enhance the exposure provided by a traditional transsphenoidal approach. Results: A total or near total (> 95%) resection was achieved in each case. One patient required reoperation for the repositioning of a fat graft to treat a cerebrospinal fluid fistula and one patient experienced a worsening of anterior pituitary function postoperatively. Five patients noted improved vision and no patient experienced further visual loss. Three patients have required subsequent treatment of small foci of recurrent or progressing tumor with stereotactic radiation therapy. No patient has received fractionated radiation therapy. Conclusion: The added exposure provided by a Le Fort I maxillotomy facilitates the resection of pituitary macroadenomas that have been incompletely resected by a traditional transnasal, trans-sphenoidal approach.

AB - Objective: The options available for the treatment of a nonsecreting pituitary macroadenoma that has been incompletely resected include reoperation, fractionated radiation therapy, and radiosurgery. Reoperation in this setting may be hindered by the same obstacles that prevented a complete resection during the initial surgical procedure, and should prompt consideration of an alternate approach or exposure. Methods: Between January 1998 and December 2003, 10 consecutive patients were referred to the Department of Neurosurgery at the University of Texas Southwestern Medical Center for the evaluation of a nonsecreting pituitary macroadenoma that measured 3 cm or greater in diameter despite having undergone an attempt at a complete resection elsewhere. Each of these patients was reoperated using a Le Fort I maxillotomy to enhance the exposure provided by a traditional transsphenoidal approach. Results: A total or near total (> 95%) resection was achieved in each case. One patient required reoperation for the repositioning of a fat graft to treat a cerebrospinal fluid fistula and one patient experienced a worsening of anterior pituitary function postoperatively. Five patients noted improved vision and no patient experienced further visual loss. Three patients have required subsequent treatment of small foci of recurrent or progressing tumor with stereotactic radiation therapy. No patient has received fractionated radiation therapy. Conclusion: The added exposure provided by a Le Fort I maxillotomy facilitates the resection of pituitary macroadenomas that have been incompletely resected by a traditional transnasal, trans-sphenoidal approach.

KW - Le Fort I maxillotomy

KW - Macroadenoma

KW - Pituitary adenoma

KW - Trans-sphenoidal surgery

UR - http://www.scopus.com/inward/record.url?scp=39449115214&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=39449115214&partnerID=8YFLogxK

U2 - 10.1055/s-2007-986426

DO - 10.1055/s-2007-986426

M3 - Article

C2 - 18449330

AN - SCOPUS:39449115214

VL - 17

SP - 369

EP - 378

JO - Journal of Neurological Surgery, Part B: Skull Base

JF - Journal of Neurological Surgery, Part B: Skull Base

SN - 2193-6331

IS - 6

ER -